0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > CD163

CD163

CD163 Molecule Information

Name:Scavenger receptor cysteine-rich type 1 protein M130
Target Synonym:CD163;M130;Hemoglobin scavenger receptor
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Approved

CD163 Protein Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
CD3-H52E8 Human Human CD163 Protein, His Tag
CD3-H52E8-structure
CD3-H52E8-sds

CD163 Molecule Synonym Name

CD163,M130

CD163 Molecule Background

Scavenger receptor cysteine-rich type 1 protein M130 (CD163) is also known as hemoglobin scavenger receptor, which is a scavenger receptor for the hemoglobin-haptoglobin complex. CD163 has also been shown to mark cells of monocyte/macrophage lineage. A soluble form of the receptor exists in plasma, commonly denoted sCD163. sCD163 is generated by ectodomain shedding of the membrane bound receptor. sCD163 is upregulated in a large range of inflammatory diseases including liver cirrhosis, type 2 diabetes, macrophage activation syndrome, Gaucher's disease, sepsis, HIV infection, rheumatoid arthritis and Hodgkin Lymphoma.

CD163 References

CD163 Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Tetrachlorodecaoxide OXO-K993; TCDO; WF-10 Approved NuvOx, Crescita Therapeutics Inflammation, Allergic rhinitis (AR), Immunological disorders Details

CD163 Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
TBI-304 HRC-304; TBI-304H; TBI-304 Phase Ⅰ Hemosol BioPharma Chemotherapy-induced anaemia Details

This web search service is supported by Google Inc.

totop